rupatadine has been researched along with mk 767 in 1 studies
| Studies (rupatadine) | Trials (rupatadine) | Recent Studies (post-2010) (rupatadine) | Studies (mk 767) | Trials (mk 767) | Recent Studies (post-2010) (mk 767) |
|---|---|---|---|---|---|
| 116 | 43 | 62 | 32 | 0 | 10 |
| Protein | Taxonomy | rupatadine (IC50) | mk 767 (IC50) |
|---|---|---|---|
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.463 | |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 0.914 | |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.463 | |
| ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.463 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morphy, R; Rankovic, Z | 1 |
1 review(s) available for rupatadine and mk 767
| Article | Year |
|---|---|
Designed multiple ligands. An emerging drug discovery paradigm.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chemistry, Pharmaceutical; Dopamine D2 Receptor Antagonists; Drug Design; Humans; Ligands; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Receptors, Histamine H1; Selective Serotonin Reuptake Inhibitors | 2005 |